Jason Cota – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Salepage : Jason Cota – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians
Archive : Jason Cota – Pharmacology of Infectious Diseases & Immunizations for Advanced Practice Clinicians Digital Download
Delivery : Digital Download Immediately
- Jason Cota is a professor.
6 hours and 26 minutes.
Audio and video formats are available.
Copyright expires on July 13, 2020.
DescriptionPurchase this video to learn how to properly prescribe, educate patients, and monitor a range of treatment regimens used to treat common acute and chronic infectious disorders. Choosing an antibacterial agent might be difficult, considering the abundance of medications on the market and the rising trend of bacterial resistance.
You will study about the pharmacology of several antibiotic classes used to treat infectious disease states observed in clinical practice. Discover the activity spectrums, pharmacokinetic properties, and metrics for evaluating therapy effects. The novel antimicrobials and developments in evidence-based treatment recommendations are highlighted. You will be better prepared at the end of this program to construct suitable and cost-effective medication regimens for enhanced treatment results.
Handouts
Advanced Practice Clinicians’ Guide on the Pharmacology of Infectious Diseases and Immunizations (3.51 MB)
Outline 107 Pages Available After Purchase
Antimicrobials
Drug categories
Pharmacokinetic Characteristics
Killing based on concentration
Killing that is time-dependent
Aftereffects of Antibiotics
Interactions with other medicines that are commonSulfa and Penicillin Antibacterial Allergies
Define the term “true allergy.”
Non-antibiotics vs. sulfonamide antibiotics
Cross-sensitivity to penicillin and cephalosporinBacteria
Differentiation
Flora normal
Pathogens that are commonFactors Contributing to Antibacterial Resistance
Trends
Resistance Mechanisms
Factors that contributeCommunity vs Hospital Acquired Methicillin-Resistant Staphylococcus Aureus
Distinguishing between CA- and HA-MRSA
Current clinical practice recommendations
Pharmacologic administrationResistance to Enterobacteriaceae
Beta-Lactamase with a Broad Spectrum (ESBL)
Pharmacologic treatment of ESBLs
Enterobacteriaceae with Carbapenem Resistance (CRE)
Pharmacologic therapy of CREsInfections of the Urinary Tract
Bacterial Etiology, Symptoms, and Diagnosis
Pyelonephritis and cystitis
Treatment for both complex and mild UTIs in pregnancy (IDSA Guideline Treatment Algorithm)
Acute
recurring and relapsingInfection with Clostridium Difficile
Risk elements
Pharmacology administration
Review of the Literature on Fecal Transplantation ProbioticsPneumonia in the Community
Bacterial pathogenesis
Treatment Typical vs. atypical Diagnosis (IDSA/ATS Guidelines) and monitoring
Inpatient vs. outpatient
Treatment based on intuitionPneumonia Caused by Healthcare
Treatment for Bacterial Etiology (IDSA/ATS Guidelines)
Infections of the Upper Respiratory Tract
Etiology of sinusitis and pharyngitis (viral vs. bacterial) Treatment
Infections of the Skin and Soft Tissues
Bacterial etiology of cellulitis
Strep. vs Staph. versus MRSA
Symptoms and treatment (IDSA Guidelines)Influenza
Clinical characteristics Diagnosis Pharmacology management
Immunizations (Adult)
Vaccine Varieties
Recommendations in general
Precautions and contraindications
Professor Jason Cota, PHARMD, MS Seminars and goods related to this topic: 3Dr. Jason Cota, PharmD, MS, is an associate professor at the University of the Incarnate Word Feik School of Pharmacy and the vice chair of the Pharmacy Practice Department. He has also worked as an infectious diseases clinical pharmacist at the San Antonio Military Medical Center for over ten years, where he is a licensed practitioner with prescription power.
The University of Texas at Austin awarded Dr. Cota a Doctor of Pharmacy and a Master of Science in Advanced Pharmacy Practice with a concentration in infectious diseases research. Along with his Master of Science degree, he completed a two-year Specialty Practice Residency in Pharmacotherapy at The University of Texas Health Science Center in San Antonio, with a focus on infectious illnesses and nephrology.
Dr. Cota is a member of the Society of Infectious Diseases Pharmacists and has spoken at several national and international conventions. His studies have focused on antibacterial and antifungal medication dosage in individuals with altered pharmacokinetics, such as critically sick burn victims and those on renal replacement therapy. He has a number of articles and book chapters published in the fields of infectious diseases and nephrology.
Disclosures for Speakers:
Jason Cota is the vice chair and associate professor of finance at the University of the Incarnate Word’s Feik School of Pharmacy. Merck pays him a speaking fee. PESI, Inc. pays Dr. Cota a speaking fee.
Jason Cota is a non-financial member of the Society of Infectious Diseases Pharmacists.
More from Categories : Health & Fitness
Reviews
There are no reviews yet.